BLINATUMOMAB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where BLINATUMOMAB was used for Neoplasm malignant.
Most Reported Side Effects for BLINATUMOMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 1,064 | 11.6% | 157 | 464 |
| Acute lymphocytic leukaemia recurrent | 977 | 10.7% | 320 | 156 |
| Cytokine release syndrome | 952 | 10.4% | 225 | 304 |
| Off label use | 590 | 6.4% | 99 | 131 |
| Death | 588 | 6.4% | 587 | 89 |
| Neurotoxicity | 530 | 5.8% | 69 | 148 |
| Drug ineffective | 345 | 3.8% | 95 | 100 |
| Headache | 335 | 3.7% | 47 | 135 |
| Neutropenia | 265 | 2.9% | 80 | 74 |
| Febrile neutropenia | 262 | 2.9% | 67 | 142 |
| Therapy non-responder | 255 | 2.8% | 105 | 14 |
| Tremor | 250 | 2.7% | 30 | 109 |
| Seizure | 232 | 2.5% | 43 | 91 |
| Acute lymphocytic leukaemia | 223 | 2.4% | 104 | 48 |
| Infection | 221 | 2.4% | 125 | 61 |
Other Indications for BLINATUMOMAB
Acute lymphocytic leukaemia (2,777)
Product used for unknown indication (2,344)
B precursor type acute leukaemia (1,791)
Acute lymphocytic leukaemia recurrent (783)
B-cell type acute leukaemia (622)
Minimal residual disease (162)
Philadelphia chromosome positive (126)
Acute lymphocytic leukaemia refractory (115)
Philadelphia chromosome negative (90)
Philadelphia positive acute lymphocytic leukaemia (86)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)